Table 2.
Case data of 27 acute leukemia patients with rhinocerebral mucormycosis.
| Case reports | Age and sex | Type of disease | Surgical debridement | Therapeutic drugs | Effective remission of the infection |
|---|---|---|---|---|---|
| Ding et al. (16) | 46/F | AML | Yes | AmB | No |
| Yamamoto et al. (17) | 42/M | AML | Yes | L-AmB, micafungin | Yes |
| Popa et al. (18) | 7/F | ALL | Yes | AmB | Yes |
| Yang et al. (19) | 1/M | ALL | No | AmB, posaconazole | No |
| Yeung et al. (20) | 57/M | AML M5a | No | L-AmB, imipenem, amikacin | No |
| Samanta et al. (21) | 8/M | ALL | Yes | L-AmB | Yes |
| Siriwardena et al. (22) | 35/F | AML | Yes | L-AmB | No |
| Siriwardena et al. (22) | 29/F | AML | Yes | L-AmB, antibiotics | Yes |
| Siriwardena et al. (22) | 42/M | AML | Yes | L-AmB | No |
| Hu et al. (23) | 1/M | ALL | No | L-AmB, voriconazole | No |
| Ojeda-Diezbarroso et al. (24) | 12/F | ALL | Yes | L-AmB, posaconazole | Yes |
| Uraguchi et al. (25) | 70/M | AML M5b | Yes | L-AmB, antibiotics | No |
| Wehl et al. (26) | 1/M | ALL | No | L-AmB, antibiotics | No |
| Mutchnick et al. (27) | 2/M | ALL | Yes | AmB, posaconazole, micafungin | Yes |
| Dworsky et al. (28) | 17/F | BCP-ALL | Yes | L-AmB, micafungin | Yes |
| Gumral et al. (29) | 40/M | ALL | Yes | L-AmB | Yes |
| Raj et al. (30) | 55/M | APL | Yes | L-AmB | Yes |
| Sigera et al. (31) | 19/M | B-ALL | Yes | L-AmB | No |
| Lerchenmüller et al. (32) | 28/M | ALL | Yes | L-AmB | Yes |
| Cofré et al. (33) | 2/F | ALL | Yes | AmB | Yes |
| Ammon et al. (34) | 24/F | AML | No | AmB, flucytosine | Yes |
| Jacobs et al. (35) | 35/F | AML | No | AmB | No |
| Jacobs et al. (35) | 17/M | ALL | No | AmB, echinocandin FK463 | Yes |
| Parkyn et al. (36) | 3/M | BCP-ALL | No | L-AmB | Yes |
| Andreani et al. (37) | 59/M | sAML | Yes | L-AmB, isavuconazole | Yes |
| Funada et al. (38) | 21/M | BCP-ALL | No | AmB | Yes |
| Brusis and Rister (39) | 12/M | ALL | Yes | AmB | Yes |
F, female; AML, acute myeloid leukemia; AmB, amphotericin B; M, male; L-AmB, liposomal amphotericin B; ALL, acute lymphoblastic leukemia; AML M5a, acute monoblastic leukemia; AML M5b, acute monocytic leukemia; BCP-ALL, B-cell precursor acute lymphoblastic leukemia; APL, acute promyelocytic leukemia; B-ALL, B-cell acute lymphoblastic leukemia; sAML, secondary acute myeloid leukemia.